Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease
Authors:
Open Access
- 13 August 2025
- journal article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (4) , 2519-2527
Abstract
Background: Drug‐coated balloon (DCB) treatment has shown outcomes comparable to drug‐eluting stent (DES) in small vessel coronary disease. However, evidence for its application in large vessel coronary artery disease (CAD) remains limited. Aims: This study evaluated the clinical impact of DCB‐based percutaneous coronary intervention (PCI) in patients with large vessel CAD. Methods: We retrospectively enrolled 550 consecutive patients with reference vessel diameter ≥ 3.0 mm treated with DCB‐based PCI and propensity‐matched them 1:1 to 550 patients who underwent conventional PCI with second‐generation DES (DES‐only group). The primary endpoint was 2‐year major adverse cardiac events (MACE), defined as a composite of cardiac death, non‐fatal myocardial infarction, definite target lesion thrombosis, and target vessel revascularization (TVR). Results: In the DCB‐based group, 390 patients (70.9%) were treated with DCB alone. Total device length was higher in the DCB group (40.0 ± 23.3 vs. 35.4 ± 23.3 mm; p = 0.001), whereas mean implanted stent length was shorter (9.6 ± 18.4 vs. 35.4 ± 23.3 mm; p < 0.001). The cumulative 2‐year incidence of MACE was significantly lower after DCB‐based PCI than after DES‐only PCI (4.3% vs. 9.7%; hazard ratio: 0.43; 95% confidence interval: 0.26 to 0.70; p = 0.001). TVR was also lower in DCB‐based PCI (3.4% vs. 7.5%; hazard ratio: 0.45; 95% confidence interval: 0.25 to 0.81; p = 0.008). There was no difference in cardiac death, myocardial infarction, or major bleeding. Conclusion: In patients with large vessel CAD, DCB‐based PCI strategy was associated with a significant reduction in MACE compared with DES‐only PCI at 2‐year follow‐up, primarily driven by a lower rate of TVR.Keywords
This publication has 35 references indexed in Scilit:
- Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessmentEuropean Heart Journal, 2015
- Drug-coated balloon therapy in coronary and peripheral artery diseaseNature Reviews Cardiology, 2013
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- The Pathology of Neoatherosclerosis in Human Coronary ImplantsJACC, 2011
- A Prospective Natural-History Study of Coronary AtherosclerosisNew England Journal of Medicine, 2011
- Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary VasomotionCirculation: Cardiovascular Interventions, 2008
- Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplastyAmerican Heart Journal, 2004
- Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trialJACC, 2001
- Coronary Angioplasty with or without Stent Implantation for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994